INTENSITY THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.83 USD | +2.13% |
|
-4.25% | -55.31% |
Chart calendar Intensity Therapeutics, Inc.
be35f7deb7.6ajt2CUI67SobW3X_jACXOwxUJCmtvj-azNS3tNaJ28.oZ6Y7whLrdrxQFzisV5jDZwHAb31_MCZHwFgj6MMElqr992qZlm63sYMVQ~f23f08996ce8c861e644f2e990536b28
Upcoming events on Intensity Therapeutics, Inc.
No events available
Past events on Intensity Therapeutics, Inc.
| 10/04/2024 01:00 am | LD Micro Invitational Conference |
| 20/03/2024 01:00 am | Roth Conference |
| 15/03/2024 01:39 am | Q4 2023 Earnings Release |
| 26/02/2024 10:15 pm | BIO CEO & Investor Conference |
| 08/12/2023 06:30 pm | San Antonio Breast Cancer Symposium - PS16-03 |
| 13/11/2023 06:31 pm | Q3 2023 Earnings Release |
| 01/11/2023 | Connective Tissue Oncology Society Meeting - Abstract Number: 1574238 |
| 05/10/2023 01:00 am | LD Micro Main Conference |
| 12/09/2023 02:00 am | H.C. Wainwright Global Investment Conference |
| 14/08/2023 05:30 pm | Q2 2023 Earnings Call |
| 14/08/2023 04:31 pm | Q2 2023 Earnings Release |
| 08/12/2022 06:30 pm | San Antonio Breast Cancer Symposium - Poster Number : PD11-02 |
| 19/11/2022 05:00 am | Connective Tissue Oncology Society Meeting - Abstract No: 1301741 |
| 11/11/2022 07:30 pm | Society for Immunotherapy of Cancer Meeting - Abstract Number: 710 |
| 10/11/2022 07:30 pm | Society for Immunotherapy of Cancer Meeting - Abstract No: 545 |
Annual results
| Fiscal Period | December | 2022 | 2023 | 2024 |
|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -8,32 -7,52 -10.68% | -10,1 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -10,5 -11,1 5.07% | -9,35 |
|
Net income Million USD | Released Forecast Spread | -7,58 | -11,9 -11,1 -6.86% | -9,35 |
|
EPS USD | Released Forecast Spread | -2,22 | -1,38 -2,32 40.52% | -0,92 |
| Announcement Date | 18/05/23 | 14/03/24 | - |
Quarterly results
| Fiscal Period | December | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -1,22 -1,30 6.02% | -2,49 -1,50 -66.03% | -3,35 -2,55 -31.48% | ||||
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -3,70 -1,38 -167.96% | -2,33 -1,26 -84.9% | -3,17 -2,41 -31.59% | ||||
|
Net income Million USD | Released Forecast Spread | -3,70 -1,38 -167.96% | -2,33 -1,26 -84.9% | -4,50 -2,41 -86.52% | ||||
|
EPS USD | Released Forecast Spread | -1,05 -0,40 -162.5% | -0,17 -0,09 -88.89% | -0,12 -0,18 33.33% | 0,00 | 0,00 | 0,00 | 0,00 |
| Announcement Date | 14/08/23 | 13/11/23 | 14/03/24 | - | - | - | - |
More events
Past sector events for Intensity Therapeutics, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- INTS Stock
- Calendar Intensity Therapeutics, Inc.